Teladoc Health (NYSE: TDOC) got crushed last year -- its price dropped 74%. But it wasn't the bear market that weighed on this telemedicine giant. Investors sanctioned the stock for specific reasons. They worried about Teladoc's inability so far to post a profit. The company's announcement of two billion-dollar goodwill impairment charges added to those concerns. And investors also gave an extra thought to the idea of competition moving in on Teladoc's territory.

Now, in 2023, it looks like the tide may be turning. The stock started the year off right, climbing about 27%.

Is this just a one-time rally? Or will this beaten-down stock truly bounce back? Here are three things to know.

Continue reading

Source Fool.com